Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat

Brain Research

Volumn 1023, Issue 1, 2004, Pages 126-133

  Bishop, Christopher ^a   Walker, Paul D ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

D1 receptor; Locomotion; Neurokinin A; Striatum; Substance P; Substantia nigra

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; LY 306740; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR; OSANETANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANNULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL TEST; INFUSION; LOCOMOTION; MALE; NEUROPHARMACOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SUBSTANTIA NIGRA;

ANIMALS; BENZAZEPINES; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-3; SUBSTANTIA NIGRA;

EID: 4444374381     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.07.039     Document Type: Article

References (49)

1. D.H. Adams, G.R. Hanson, and K.A. Keefe Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum Neuroscience 102 2001 843 851
2. M.J. Bannon, P.J. Elliott, and E.B. Bunney Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists Brain Res. 427 1987 31 37
3. P. Baruch, F. Artaud, G. Godeheu, L. Barbeito, J. Glowinski, and A. Cheramy Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons Neuroscience 25 1988 889 898
4. C. Bishop, and P.D. Walker Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats Neuroscience 121 2003 649 657
5. J.P. Bolam, J.J. Hanley, P.A.C. Booth, and M.D. Bevan Synaptic organization of the basal ganglia J. Anat. 196 2000 527 542
6. F. Bordi, and E. Meller Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats Brain Res. 504 1989 276 283
7. E. Cellier, L. Barbot, D. Regoli, and R. Couture Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat Br. J. Pharmacol. 122 1997 643 654
8. E. Cellier, L. Barbot, S. Iyengar, and R. Couture Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat Br. J. Pharmacol. 127 1999 717 728
9. X. Emonds-Alt, D. Bichon, J.P. Ducoux, M. Heaulme, B. Miloux, M. Poncelet, V. Proietto, D. Van Broeck, P. Vilain, and G. Neliat SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor Life Sci. 56 1995 L27 L32
10. T. Futami, Y. Hatanaka, K. Matsushita, and S. Furuya Expression of substance P receptor in the substantia nigra Mol. Brain Res. 54 1998 183 198
11. C.R. Gerfen The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia Annu. Rev. Neurosci. 15 1992 285 320
12. C.R. Gerfen, and W.S. Young III Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study Brain Res. 460 1988 161 167
13. C. Gueudet, V. Santucci, P. Soubrie, and G. Le Fur Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs Synapse 33 1999 71 79
14. G.R. Hanson, L. Bush, K.A. Keefe, and M.E. Alburges Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine J. Neurochem. 82 2002 1171 1178
15. M. Herrera-Marschitz, I. Christensson-Nylander, T. Sharp, W. Staines, M. Reid, T. Hokfelt, L. Terenius, and U. Ungerstedt Striato-nigral dynorphin and substance P pathways in the rat: II. Functional analysis Exp. Brain Res. 64 1986 193 207
16. P.A. Hipskind, J.J. Howbert, R.F. Bruns, S.S. Cho, T.A. Crowell, M.M. Foreman, D.R. Gehlert, S. Iyengar, K.W. Johnson, J.H. Krushinski, D.L. Li, K.L. Lobb, N.R. Mason, B.S. Muehl, J.A. Nixon, L.A. Phebus, D. Regoli, R.M. Simmons, P.G. Threlkeld, D.C. Waters, and B.D. Gitter 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists J. Med. Chem. 39 1996 736 748
17. C. Humpel, and A. Saria Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat Neurosci. Lett. 157 1993 223 226
18. M. Jung, J.C. Michaud, R. Steinberg, M.C. Barnouin, A. Hayar, G. Mons, J. Souilhac, X. Emonds-Alts, P. Soubrie, and G. Le Fur Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation Neuroscience 74 1996 403 414
19. K.D. Keegan, G.N. Woodruff, and R.D. Pinnock The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro Br. J. Pharmacol. 105 1992 3 5
20. A.E. Kelley, M. Cador, and L. Stinus Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat Psychopharmacology (Berl) 85 1985 37 46
21. J.E. Krause, J.M. Chirgwin, M.S. Carter, Z.S. Xu, and A.D. Hershey Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A Proc. Natl. Acad. Sci. U. S. A. 84 1987 881 885
22. T. Lee, T. Kaneko, K. Taki, and N. Mizuno Preprodynorphin-, preproenkephalin-, and preprotachykinin-expressing neurons in the rat neostriatum: an analysis by immunocytochemistry and retrograde tracing J. Comp. Neurol. 386 1997 229 244
23. U. Liminga, and L.M. Gunne Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats Behav. Brain Res. 57 1993 93 99
24. H. Liu, J.L. Brown, L. Jasmin, J.E. Maggio, S.R. Vigna, P.W. Mantyh, and A.I. Basbaum Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors Proc. Natl. Acad. Sci. U. S. A. 91 1994 1009 1013
25. 3H]SP as the radioligand Brain Res. 307 1984 147 165
26. Y. Minabe, K. Emori, A. Toor, G.E. Stutzmann, and C.R. Ashby Jr. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study Synapse 22 1996 35 45
27. E. Nalivaiko, J.C. Michaud, P. Soubrie, G. Le Fur, and P. Feltz Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study Neuroscience 78 1997 745 757
28. K.M. O'Boyle, D.E. Gaitanopoulos, M. Brenner, and J.L. Waddington Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor Neuropharmacology 28 1989 401 405
29. W.T. O'Connor Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis Nucl. Med. Biol. 25 1998 743 746
30. D. Orosz, and J.P. Bennett Jr. Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease Eur. J. Pharmacol. 182 1990 509 514
31. F. Oury-Donat, P. Carayon, O. Thurneyssen, V. Pailhon, X. Emonds-Alt, P. Soubrie, and G. Le Fur Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells J. Pharmacol. Exp. Ther. 274 1995 148 154
32. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1998 Academic Press New York, NY
33. M.S. Reid, M. Herrera-Marschitz, T. Hokfelt, N. Lindefors, H. Persson, and U. Ungerstedt Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms Exp. Brain Res. 82 1990 293 303
34. M.S. Reid, M. Herrera-Marschitz, and U. Ungerstedt Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats J. Neurochem. 57 1991 970 974
35. A. Reiner, L. Medina, and S.N. Haber The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans Neuroscience 88 1999 775 793
36. A. Ribeiro-da-Silva, and T. Hokfelt Neuroanatomical localisation of substance P in the CNS and sensory neurons Neuropeptides 34 2000 256 271
37. D.N. Ruskin, S.S. Rawji, and J.R. Walters Effects of full D1 agonists on firing rates in globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons with the partial agonist SKF 38393 J. Pharmacol. Exp. Ther. 268 1998 272 281
38. M. Saffroy, Y. Torrens, J. Glowinski, and J.C. Beaujouan Autoradiographic distribution of tachykinin NK(2) binding sites in the rat brain: comparison with NK(1) and NK(3) binding sites Neuroscience 116 2003 761 773
39. A. Saria The tachykinin NK1 receptor in the brain: pharmacology and putative functions Eur. J. Pharmacol. 375 1999 51 60
40. C. Severini, G. Improta, G. Falconieri-Erspamer, S. Salvadori, and V. Erspamer The tachykinin peptide family Pharmacol. Rev. 54 2002 285 322
41. S.P. Sivam, and J.E. Krause Tachykinin systems in spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic innervation on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA J. Neurochem. 59 1992 2278 2284
42. Y. Smith, M.D. Bevan, E. Shink, and J.P. Bolam Microcircuitry of the direct and indirect pathways of the basal ganglia Neuroscience 86 1998 353 387
43. A.J. Stoessl Localization of striatal and nigral tachykinin receptors in the rat Brain Res. 646 1994 13 18
44. A.J. Stoessl, E. Szczutkowski, B. Glenn, and I. Watson Behavioural effects of selective tachykinin agonists in midbrain dopamine regions Brain Res. 565 1991 254 262
45. A.J. Stoessl, M. Brackstone, N. Rajakumar, and C.J. Gibson Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist Brain Res. 700 1995 115 120
46. J.M. Tepper, L.P. Martin, and D.R. Anderson GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons J. Neurosci. 15 1995 3092 3103
47. J.Q. Wang, and J.F. McGinty The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors J. Pharmacol. Exp. Ther. 281 1997 972 982
48. B.L. Waszczak, L.P. Martin, H.E. Finlay, N. Zahr, and J.R. Stellar Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia J. Pharmacol. Exp. Ther. 300 2002 850 861
49. C.J. Whitty, P.D. Walker, D.J. Goebel, M.S. Poosch, and M.J. Bannon Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra Neuroscience 64 1995 419 425